Clinical Trial Update: The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy [Phase 3]

View source ↗

Summary

This Phase 3 trial investigates the amount of radioactive iodine (Iodine-131) needed to ablate thyroid remnants after thyroidectomy. Sponsor: University of Hels…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Neoplasms

Drugs mentioned

• Iodine-131 (radioactive iodine) (iodine-131)

Snippet

Sponsor: University of Helsinki | Conditions: Thyroid Neoplasms | Phase 3 | Status: UNKNOWN